Furthermore, the NF-κB/iNOS pathway may be involved in the mechanism of CUMS-induced colon tissue injury, and this might provide new insight into a potential therapeutic strategy for the treatment of depression with GI dysfunction. This evidence concerns the gene NFKB1 and depressive symptom measurement.